Inventor
Olaf Panknin
Inventor
Berlin, DE
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07CAcyclic or carbocyclic compounds9%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture3%
PatentTitleYear
10,975,060High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging202110,919,862Fused imidazoles as mIDH1 inhibitors202110,722,601Gadolinium chelate compounds for use in magnetic resonance imaging202010,442,772Benzimidazol-2-amines as mIDH1 inhibitors201910,414,7345-hydroxyalkylbenzimidazoles as mIDH1 inhibitors201910,370,339N-Methylbenzimidazoles as mIDH1 inhibitors201910,179,1232-aryl- and 2-arylalkyl-benzimidazoles as mIDH1 inhibitors201910,137,209Gadolinium chelate compounds for use in magnetic resonance imaging201810,137,1101-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors20189,957,235Benzimidazol-2-amines as mIDH1 inhibitors20189,951,027Benzimidazol-2-amines as MIDH1 inhibitors2018Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2018–2021Patents assigned to Bayer Pharma AG (11)· patent assignee history
2018–2021Based in Berlin, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| Bayer Pharma AG | 11 | 2018–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Berlin, DE | 11 | 2018–2021 |